Lupin Stock Rises 2% After US FDA Approval
Shares of Lupin Ltd surged 2% to touch a day’s high of Rs 2,244.50 on 5th February after the company announced the launch of Topiramate...
Tag : Lupin Ltd
Lupin Stock Drops 2.5% Despite Recent Deal
Shares of Lupin Ltd fell 2.5% after touching a day’s high of Rs 2,148 on 2nd February. This fall occurred despite the company announcing two...
Lupin Shares Gain 1% on Arm Inking License and Supply Agreement
Shares of Lupin Ltd were trading in the green and almost 2% higher on 21 January after the company’s subsidiary, Lupin Atlantis Holdings SA, announced...
Lupin Shares Trade Flat Despite Exclusive China Pact for Diabetes, Obesity Drug
Shares of Lupin Ltd are trading flat on 30th December after touching a day’s high of Rs 2,098.80, despite the company saying it has inked...
Lupin Shares Gain 1% as Unit Receives EIR Status from USFDA
Shares of Lupin Ltd were trading in the green and almost 2% higher on 17 December after the company received the EIR from the USFDA. ...
Lupin Signs US Licensing Deal for Cancer Biosimilar; Shares End Flat
Shares of Lupin Ltd ended flat on 4th December, even though the firm said it has signed an exclusive licensing agreement with US-based Valorum Biologics...
Lupin’s New Jersey Unit Gets One USFDA Observation; Shares Trade Flat
Shares of Lupin Ltd are trading flat after reaching a day’s high of Rs 1,970.50 on 13th October, following an update on its New Jersey...
Lupin Falls 2% After USFDA Issues OAI for Pithampur Unit 2
Shares of Lupin Ltd fell 2% on 6th October after touching a day’s high of Rs 1,972.90. This occurred as the company announced that the...
Lupin Shares Trading Flat as Unit Acquires VISUfarma for Rs 1,970 Crore
Shares of Lupin Ltd are trading flat after touching a day’s high of Rs 1,958 on 29th September, even as the company announced that its...
Lupin Shares Slump as Nagpur Facility Gets 6 Observations
Shares of Lupin Ltd were trading in the red and 1.5% lower on 17 September after the company’s Nagpur injectable facility received six observations from...